{"id":116,"date":"2021-12-09T11:27:21","date_gmt":"2021-12-09T11:27:21","guid":{"rendered":"https:\/\/cancerequality.eu\/?page_id=116"},"modified":"2025-05-26T08:05:45","modified_gmt":"2025-05-26T08:05:45","slug":"speakers","status":"publish","type":"page","link":"https:\/\/cancerequality.eu\/lv\/speakers\/","title":{"rendered":"Run\u0101t\u0101ji"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"speakers.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-116","page","type-page","status-publish","hentry"],"acf":{"speakers":[{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2021\/12\/409053_8164_2362x3543.jpg","name":"Olga Valci\u0146a","position":"Latvijas Onkolo\u0123ijas pacientu organiz\u0101ciju apvien\u012bbas \u201cOnkoalianse\u201d dibin\u0101t\u0101ja","description":"Olga Valci\u0146a ir melanomas pacientu atbalsta biedr\u012bbas \u201cSoli priek\u0161\u0101 melanomai\u201d dibin\u0101t\u0101ja un vad\u012bt\u0101ja. Melanomas paciente kop\u0161 2017. gada. Mg. biol. Olga Valci\u0146a ir viena no ener\u0123isk\u0101kaj\u0101m pacientu aizst\u0101v\u0113m Latvij\u0101, Latvijas onkolo\u0123ijas pacientu organiz\u0101ciju apvien\u012bbas \u201cOnkoalianse\u201d dibin\u0101\u0161anas iniciatore un t\u0101s valdes locekle. Vi\u0146as vad\u012bt\u0101 biedr\u012bba \u201cSoli priek\u0161\u0101 melanomai\u201d akt\u012bvi c\u012bn\u0101s par lab\u0101ku \u0101rst\u0113\u0161anas pieejam\u012bbu un kvalit\u0101ti melanomas pacientiem, kop\u0101 ar \u201cOnkoaliansi\u201d l\u012bdzdarbojoties Latvijas onkolo\u0123ijas politikas pilnveido\u0161an\u0101. Kop\u0161 2019. gada Olga Valci\u0146a ir iesaist\u012bjusies Eiropas Melanomas pacientu t\u012bkla aktivit\u0101t\u0113s, sekm\u0113jot to, ka Latvij\u0101 p\u0113d\u0113jos gados ir iev\u0113rojami uzlabojusies jaun\u0101ko z\u0101\u013cu pieejam\u012bba melanomas \u0101rst\u0113\u0161anai, tiek iev\u0113rotas starptautisk\u0101s vadl\u012bnijas melanomas diagnostik\u0101, terapij\u0101 un nov\u0113ro\u0161an\u0101. Olgas Valci\u0146as galvenais moto pacientu aizst\u0101v\u012bbas jom\u0101: \u201cIzgl\u012btoti pacienti dz\u012bvo ilg\u0101k un lab\u0101k. Ja pacienti v\u0113las re\u0101lus uzlabojumus, vi\u0146iem j\u0101b\u016bt gudriem, vienm\u0113r \u013coti labi sagatavotiem un j\u0101veido sava reput\u0101cija un atpaz\u012bstam\u012bba\u201d. P\u0113c izgl\u012bt\u012bbas Olga Valci\u0146a ir mikrobiolo\u0123e, p\u0101rtikas dro\u0161\u012bbas, dz\u012bvnieku vesel\u012bbas un vides zin\u0101tniskaj\u0101 instit\u016bt\u0101 BIOR ir direktora vietniece laboratoriju jaut\u0101jumos."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2021\/12\/JohnFRyanphoto_final.jpg","name":"D\u017eons Raiens (John Ryan)","position":"Eiropas Komisijas Vesel\u012bbas un p\u0101rtikas nekait\u012bguma \u0123ener\u0101ldirektor\u0101ta (\u0122D SANTE) Sabiedr\u012bbas vesel\u012bbas direktor\u0101ta direktors","description":"D\u017eons Raiens ir Eiropas Komisijas Vesel\u012bbas un p\u0101rtikas nekait\u012bguma \u0123ener\u0101ldirektor\u0101ta (\u0122D SANTE) Sabiedr\u012bbas vesel\u012bbas direktor\u0101ta direktors (kop\u0161 2016. gada). EK p\u0101rst\u0101vis Eiropas Slim\u012bbu Profilakses un Kontroles centra (ECDC) vald\u0113. Darb\u012bbas galven\u0101s priorit\u0101tes \u2013 Covid pand\u0113mijas vad\u012bba, ES V\u0113\u017ea uzveik\u0161anas pl\u0101na ievie\u0161ana, antibakteri\u0101l\u0101 rezistence, vakcin\u0101cijas politika, vesel\u012bbu, t.sk., izp\u0113ti atbalsto\u0161o finan\u0161u instrumentu ievie\u0161ana."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Bettina_Ryll_photo_F.jpg","name":"Betina Rilla (Bettina Ryll, MD\/PhD)","position":"Eiropas Melanomas pacientu t\u012bkla dibin\u0101t\u0101ja","description":"Dr. Betina Rilla ir Eiropas Melanomas pacientu t\u012bkla dibin\u0101t\u0101ja un ES V\u0113\u017ea misijas valdes locekle. Dr. Betina Rilla izveidoja Eiropas Melanomas pacientu t\u012bklu p\u0113c tam, kad melanomas d\u0113\u013c bija zaud\u0113jusi savu v\u012bru, vienlaikus padzi\u013cin\u0101ti piev\u0113r\u0161oties uz pacientu centr\u0113tiem kl\u012bniskiem p\u0113t\u012bjumiem, jo \u012bpa\u0161i, inovat\u012bviem p\u0113t\u012bjumu dizainiem un jaunu z\u0101\u013cu izstr\u0101des koncepcij\u0101m. Laika gait\u0101 vi\u0146as darb\u012bbas fokuss tika p\u0101rorient\u0113ts uz pragmatiskiem un ilgtsp\u0113j\u012bgiem vesel\u012bbas apr\u016bpes mode\u013ciem, kas nodro\u0161ina inovat\u012bvo z\u0101\u013co pieejam\u012bbu v\u0113\u017ea pacientiem un stimul\u0113 ilgtsp\u0113j\u012bgas inov\u0101cijas kopum\u0101. Kop\u0161 2019. gada Dr. Rilla ir ES V\u0113\u017ea misijas valdes locekle, kuras darb\u012bba galvenok\u0101rt  velt\u012bta ar personaliz\u0113to medic\u012bnu saist\u012bt\u0101m rekomend\u0101cij\u0101m. Vi\u0146as motiv\u0101cija liel\u0101 m\u0113r\u0101 ir balst\u012bta personiskaj\u0101 pieredz\u0113 un pacientu intere\u0161u aizst\u0101v\u012bb\u0101, k\u0101 ar\u012b v\u0113lm\u0113 redz\u0113t zin\u0101tniskos sasniegumus iesp\u0113jami \u0101tri sniedzam pacientiem re\u0101lus ieguvumus. Vi\u0146a ir p\u0101rliecin\u0101ta, ka  pier\u0101d\u012bjumos balst\u012btas prakses un p\u0113t\u012bjumu zin\u0101tniski pamatota ievie\u0161ana ir \u013coti b\u016btiska personaliz\u0113t\u0101s medic\u012bnas att\u012bst\u012bbai. No 2015. l\u012bdz 2018. gadam Dr Rilla vad\u012bja , Eiropas medic\u012bnisk\u0101s onkolo\u0123ijas biedr\u012bbas (ESMO) Pacientu intere\u0161u aizst\u0101v\u012bbas darba grupu \u2013 t\u0101 bija pirm\u0101 reize organiz\u0101cijas v\u0113stur\u0113, kad \u0161is amats tika uztic\u0113ts personai, kas nav onkologs. \u0160\u012b grupa ir atbild\u012bga par pacientu intere\u0161u aizst\u0101v\u012bbas jom\u0101 paveikt\u0101 atspogu\u013cojumu ikgad\u0113j\u0101 ESMO san\u0101ksm\u0113, organiz\u0113 darbsemin\u0101rus pla\u0161\u0101kam pacientu intere\u0161u aizst\u0101vju un medi\u0137u lokam un \u012bsteno ESMO padomdev\u0113ja funkcijas. Pa\u0161reiz Dr. Rilla ir ESMO P\u0113tniecisk\u0101s im\u016bnonkolo\u0123ijas grupas biedre. Dr Rillai ir medic\u012bnas zin\u0101t\u0146u gr\u0101ds, kas ieg\u016bts Berl\u012bnes Br\u012bvaj\u0101 universit\u0101t\u0113, V\u0101cij\u0101 un biomedic\u012bnisko zin\u0101t\u0146u doktora gr\u0101ds, kas ieg\u016bts Londonas universit\u0101tes koled\u017e\u0101, Apvienotaj\u0101 Karalist\u0113."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/MENIA_KOUKOUGIANNI_final-1.jpg","name":"Menija Kukud\u017eani (Menia Koukougianni)","position":"NVO \u201cKarkinaki\u201d l\u012bdzdibin\u0101t\u0101ja un vad\u012bt\u0101ja, Grie\u0137ija","description":"Menija Kukud\u017eani ir NVO \u201cKarkinaki\u201d \u2013 pacientu organiz\u0101cijas, kas aizst\u0101v ar v\u0113zi slimo b\u0113rnu un pusaud\u017eu intereses un ko 2015. gad\u0101 izveidoja vi\u0146u vec\u0101ki, l\u012bdzdibin\u0101t\u0101ja un vad\u012bt\u0101ja. K\u0101 vec\u0101ku intere\u0161u aizst\u0101ve vi\u0146a darbojas Eiropas t\u012bkla, kas apvieno izdz\u012bvoju\u0161os p\u0113c b\u0113rn\u012bb\u0101 vai pusaud\u017ea gados pieredz\u0113t\u0101 audz\u0113ja (PanCare), vald\u0113, Starptautiskaj\u0101 Eiropas B\u0113rnu v\u0113\u017ea (CCI Europe) organiz\u0101cij\u0101, ir Eiropas Labas kl\u012bnisk\u0101s prakses foruma (EFGCP) pediatrisk\u0101s medic\u012bnas darba grupas biedre, k\u0101 ar\u012b biedre EURORDIS Datu konsultat\u012bvaj\u0101 grup\u0101. M. Kukud\u017eani ar\u012b darbojas Eiropas V\u0113\u017ea izp\u0113tes un \u0101rst\u0113\u0161anas organiz\u0101cijas (EORTC) pacientu ekspertu grup\u0101 un ir Eiropas Z\u0101\u013cu a\u0123ent\u016bras (EMA) onkolo\u0123ijas zin\u0101tniski konsultat\u012bv\u0101s grupas locekle. Nupat k\u0101 vi\u0146a ir k\u013cuvusi ar\u012b par biedri antibakteri\u0101l\u0101s rezistences (AMR) pacientu Eiropas grup\u0101."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2021\/12\/Sonata_Jarmalaite-1.jpg","name":"Sonata Jarmalaite (Sonata Jarmalait\u0117)","position":"Lietuvas Nacion\u0101l\u0101 v\u0113\u017ea instit\u016bta izpilddirektore, Vi\u013c\u0146as universit\u0101tes \u0122en\u0113tikas un Dabaszin\u0101t\u0146u centra profesore, Lietuva","description":"Sonatai Jarmalaitei ir ma\u0123istra gr\u0101ds biolo\u0123ij\u0101 un medic\u012bniskaj\u0101 biolo\u0123ij\u0101, k\u0101 ar\u012b doktora gr\u0101ds biolo\u0123ij\u0101 (\u0123en\u0113tik\u0101). Savas p\u0113cdoktorant\u016bras studijas Somijas Arodvesel\u012bbas instit\u016bt\u0101 (Helsiniki) vi\u0146a velt\u012bja v\u0113\u017ea molekul\u0101rbiolo\u0123ijai un biomar\u0137ieru izp\u0113tei. Profesores pa\u0161reiz\u0113j\u0101s zin\u0101tnisk\u0101s aktivit\u0101tes galvenok\u0101rt fokus\u0113tas uz genomisko tehnolo\u0123iju pielietojumu transl\u0101cijas izp\u0113t\u0113 onkolo\u0123ij\u0101. Par zin\u0101tniski p\u0113tniecisko darbu \u201cN\u0101kam\u0101s paaudzes v\u0113\u017ea biomar\u0137ieri\u201d Sonata Jarmalaite sa\u0146\u0113ma Lietuvas Zin\u0101tnes balvu. Vi\u0146a ir ar\u012b apbalvota ar Lietuvas Di\u017ekunigai\u0161a \u0122edimina ordeni. Sonata Jarmalaite darbojas Nacion\u0101laj\u0101 v\u0113\u017ea profilakses un kontroles komitej\u0101, Nacion\u0101laj\u0101 vesel\u012bbas padom\u0113, Nacion\u0101laj\u0101 komitej\u0101, kas atbild\u012bga par vair\u0101k nek\u0101 1 miljonu v\u0113rta genoma projekta ievie\u0161anu, ir nacion\u0101l\u0101 p\u0101rst\u0101ve Eiropas Komisijas V\u0113\u017ea apkak\u0161grup\u0101, un Lietuvas Onkologu apvien\u012bbas vad\u012bbas komitejas priek\u0161s\u0113d\u0113t\u0101ja."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Partha_Basu_F-1.jpg","name":"Partha Basu","position":"Starptautisk\u0101s V\u0113\u017ea p\u0113tniec\u012bbas a\u0123ent\u016bras (SVPA) agr\u012bn\u0101s atkl\u0101\u0161anas, profilakses un infekciju noda\u013cas vad\u012bt\u0101ja vietnieks","description":"Dr. Partha Basu ir medic\u012bnas doktors ginekolo\u0123ij\u0101, kur\u0161 savu doktora disert\u0101ciju aizst\u0101v\u0113jis kl\u012bniskaj\u0101 onkolo\u0123ij\u0101. Vi\u0146\u0161 ieguvis onkoginekologa izgl\u012bt\u012bbu Londonas Imp\u0113rijas koled\u017e\u0101, London\u0101. 1997. gad\u0101 vi\u0146\u0161 k\u013cuva par Indijas \u010citaranjanas Nacion\u0101l\u0101 v\u0113\u017ea instit\u016bta onkoginekolo\u0123ijas noda\u013cas vad\u012bt\u0101ju, ie\u0146emot \u0161o amatu l\u012bdz pat 2015. gadam, kad uzs\u0101ka darbu Francij\u0101 \u2013 Pasaules vesel\u012bbas organiz\u0101cijas Starptautiskaj\u0101 v\u0113\u017ea p\u0113tniec\u012bbas a\u0123ent\u016br\u0101. \u0160obr\u012bd vi\u0146\u0161 ir \u0161\u012bs iest\u0101des agr\u012bn\u0101s atkl\u0101\u0161anas, profilakses un infekciju noda\u013cas vad\u012bt\u0101ja vietnieks. Dr. Basu ir galvenais p\u0113tnieks vair\u0101kos p\u0113t\u012bjumos, ko finans\u0113 ASV Nacion\u0101lais vesel\u012bbas instit\u016bts, Bila un Melindas Geitsu fonds, Eiropas Komisija, Hronisko Slim\u012bbu glob\u0101l\u0101 alianse, Apvienot\u0101s karalistes Medic\u012bnisk\u0101s P\u0113tniec\u012bbas padome, Norv\u0113\u0123ijas P\u0113tniec\u012bbas padome. Dr. Partha Basu ir 185 zin\u0101tnisku publik\u0101ciju autors, kas starptautiski cit\u0113tas teju 5000 rei\u017eu."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Hasardzhiev_photo_labots.jpg","name":"Stanimirs Hasard\u017eijevs (Stanimir Hasardziev)","position":"Pacientu partner\u012bbas t\u012bkla \u0123ener\u0101lsekret\u0101rs, Bulg\u0101rija","description":"Dr. Stanimirs Hasard\u017eijevs ir Bulg\u0101rijas Nacion\u0101l\u0101s pacientu organiz\u0101cijas (liel\u0101k\u0101 pacientu organiz\u0101ciju alianse Bulg\u0101rij\u0101, kas apvieno aptuveni 80 slim\u012bbu specifiskas dal\u012bborganiz\u0101cijas un p\u0101rst\u0101v pacientu, kuri sirgst ar da\u017e\u0101d\u0101m soci\u0101li noz\u012bm\u012bg\u0101m slim\u012bb\u0101m, intereses visos 28 valsts re\u0123ionos) viens no dibin\u0101t\u0101jiem un pa\u0161reiz\u0113jais t\u0101s izpilddirektors. Vi\u0146\u0161 ilgsto\u0161i savu darbu ir velt\u012bjis pacientu intere\u0161u un ties\u012bbu aizst\u0101v\u012bbai. \u0160obr\u012bd Dr. Hasard\u017eijevs ir Bulg\u0101rijas Personaliz\u0113t\u0101s medic\u012bnas asoci\u0101cijas (BAPEMED) priek\u0161s\u0113d\u0113t\u0101js. Vi\u0146\u0161 pilda ar\u012b iniciat\u012bvas \u201cVesel\u012bbas partner\u012bba\u201d sekret\u0101ra pien\u0101kumus \u2013 \u0161\u012b organiz\u0101cija tika ofici\u0101li izveidota 2015. gada mart\u0101 k\u0101 Ministru Kabineta past\u0101v\u012bga konsultat\u012bv\u0101 padome. Dr. Hasard\u017eijevs ir darbojies ar\u012b starptautisk\u0101 m\u0113rog\u0101 \u2013 l\u012bdz 2019. gadam divus termi\u0146us p\u0113c k\u0101rtas bijis Eiropas Pacientu Foruma valdes loceklis, k\u0101 ar\u012b ir biedrs vair\u0101k\u0101s re\u0123ion\u0101l\u0101s un starptautisk\u0101s organiz\u0101cij\u0101s un t\u012bklos, piem\u0113ram, Pasaules Hepat\u012bta Alians\u0113, Eiropas Kopienas Konsultat\u012bvaj\u0101 padom\u0113, Starptautiskaj\u0101 Veiktsp\u0113jas veicin\u0101\u0161ana alians\u0113 u.c. \u0160obr\u012bd vi\u0146\u0161 ir ar\u012b nesen dibin\u0101t\u0101s organiz\u0101cijas CEE4Health \u0123ener\u0101lsekret\u0101rs."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Francisco_Goncalves.jpg","name":"Fran\u010desko Roha Gonzaless (Francisco Rocha Gon\u00e7alves)","position":"Porto universit\u0101tes Medic\u012bnas fakult\u0101tes viesprofesors","description":"Fran\u010desko Nuno Roha Gonzaless \u0161obr\u012bd ir tirgus pieejam\u012bbas un publisko attiec\u012bbu vad\u012bt\u0101js Sanofi Portug\u0101les organiz\u0101cij\u0101, k\u0101 ar\u012b Porto universit\u0101tes Medic\u012bnas fakult\u0101tes viesprofesors. Iepriek\u0161  bijis vesel\u012bbas tehnolo\u0123iju vad\u012bbas direktors Portug\u0101les liel\u0101kaj\u0101 priv\u0101to kl\u012bniku grup\u0101 Luz Saude, k\u0101 ar\u012b PPP slimn\u012bcas vad\u012bbas komisijas biedrs, k\u0101 ar\u012b Portug\u0101les liel\u0101k\u0101 v\u0113\u017ea centra IPO Porto valdes loceklis. Vi\u0146am ir doktora gr\u0101ds vad\u012bbzin\u0101tn\u0113s (Lisabona, Portug\u0101le) un ekonomisk\u0101 izgl\u012bt\u012bba (Porto, Portug\u0101le). Ir vair\u0101ku starptautisko cit\u0113jamu publik\u0101ciju autors, regul\u0101ri piedal\u0101s ar savu darb\u012bbas jomu saist\u012btos nacion\u0101las un starptautiskas noz\u012bmes pas\u0101kumos."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Jin-Young-PARK-1.jpg","name":"Jina Junga P\u0101rka (Jin Young Park)","position":"Starptautisk\u0101s v\u0113\u017ea izp\u0113tes a\u0123ent\u016bras zin\u0101tniece","description":"Dr. Jina Junga P\u0101rka Kembrid\u017eas universit\u0101t\u0113 ir ieguvusi gan filozofijas ma\u0123istra, gan epideomolo\u0123ijas doktora gr\u0101du. Vi\u0146a ir zin\u0101tniece Pasaules Vesel\u012bbas organiz\u0101cijas Starptautiskaj\u0101 v\u0113\u017ea izp\u0113tes a\u0123ent\u016br\u0101 (IARC), kas atrodas Lion\u0101, Francij\u0101. Vi\u0146as p\u0113tnieciskais darbs agr\u012bnas diagnostikas, profilakses un infekciju jom\u0101 ir saist\u012bts ar virkni pla\u0161u starptautisku epidemiolo\u0123isko p\u0113t\u012bjumu par Helicobacter pylori (H. pylori) infekciju un ku\u0146\u0123a v\u0113zi, un t\u0101 m\u0113r\u0137is ir efekt\u012bvu profilakses strat\u0113\u0123iju izp\u0113te un ievie\u0161ana. Vi\u0146a ir vado\u0161\u0101 p\u0113tniece liela m\u0113roga randomiz\u0113tos kl\u012bniskos p\u0113t\u012bjumos, kas velt\u012bti H. pylori izskau\u0161anas un endoskopisk\u0101s kontroles noz\u012bmei ku\u0146\u0123a v\u0113\u017ea samazin\u0101\u0161an\u0101, glob\u0101l\u0101s aptauj\u0101s, kuru m\u0113r\u0137is ir sistematiz\u0113ti izprast ku\u0146\u0123a v\u0113\u017ea riska faktoru un ar tiem saist\u012bto vesel\u012bbas izn\u0101kumu rad\u012bto slogu. T\u0101pat vi\u0146as p\u0113tnieciskais darbs ir velt\u012bts ar ku\u0146\u0123a v\u0113\u017ea agr\u012bnu diagnostiku saist\u012btu biomar\u0137ieru (piem., da\u017e\u0101du metabolisma aspektu) identifik\u0101cijai."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Photo-Curigliano_final.jpg","name":"D\u017euzepe Kurid\u017eli\u0101no (Giuseppe Curigliano)","position":"ESMO Vadl\u012bniju komitejas priek\u0161s\u0113d\u0113t\u0101js","description":"D\u017euzepe Kurid\u017eli\u0101no (MD, PhD) ir medic\u012bnisk\u0101s onkolo\u0123ijas profesors Mil\u0101nas Universit\u0101t\u0113, Eiropas onkolo\u0123ijas instit\u016bta agr\u012bn\u0101s z\u0101\u013cu izstr\u0101des noda\u013cas vad\u012bt\u0101js (It\u0101lija). Kop\u0161 2018. gada vi\u0146\u0161 ir It\u0101lijas Nacion\u0101l\u0101s vesel\u012bbas padomes biedrs, 2019. gad\u0101 pild\u012bja The Lega Nazionale Lotta ai Tumori zin\u0101tnisk\u0101s komitejas priek\u0161s\u0113d\u0113t\u0101ja pien\u0101kumus. Kop\u0161 2011. gada vi\u0146\u0161 darbojas St. Gallen konferences zin\u0101tniskaj\u0101 komitej\u0101, k\u0101 ar\u012b bija \u0161is konferences zin\u0101tniskais l\u012bdzpriek\u0161s\u0113d\u0113t\u0101js 2017., 2019. un 2021. gad\u0101. Vi\u0146\u0161 ir ar\u012b pild\u012bjis zin\u0101tnisk\u0101 l\u012bdzpriek\u0161s\u0113d\u0113t\u0101ja pien\u0101kumus ESMO Kr\u016bts v\u0113\u017ea kongresos 2019., 2020. un 2021. gad\u0101. Ir Annals of Oncology redkol\u0113\u0123ijas padomes loceklis, The Breast l\u012bdzredaktors, Cancer Treatment Reviews l\u012bdzredaktors, European Journal of Cancer redaktora biedrs, Journal of Clinical Oncology redaktors. Dr. Kurid\u017eli\u0101no \u0161obr\u012bd veic ESMO Vadl\u012bniju komitejas priek\u0161s\u0113d\u0113t\u0101ja pien\u0101kumus, bet savulaik bijis ar\u012b \u0161is organiz\u0101cijas Nomin\u0101ciju komitejas priek\u0161s\u0113d\u0113t\u0101js. 2017. gad\u0101 V\u012bn\u0113 vi\u0146\u0161 k\u0101 pirmais sa\u0146\u0113ma Eiropas Onkolo\u0123ijas skolas (ESO) iedibin\u0101to Umberto Veron\u0113zi (Umberto Veronesi) piemi\u0146as balvu. Prof. Kurid\u017eli\u0101no ir vair\u0101k nek\u0101 530 starptautiski cit\u0113jamu publik\u0101ciju autors\/l\u012bdzautors."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/02\/Daniels_Pavluts_foto-1.jpg","name":"Daniels Pav\u013cuts","position":"Latvijas Republikas vesel\u012bbas ministrs","description":"Daniels Pav\u013cuts vesel\u012bbas ministra amat\u0101 st\u0101j\u0101s 2021. gada 7. janv\u0101r\u012b. Pirms tam vi\u0146\u0161 bija partiju apvien\u012bbas \u201cAtt\u012bst\u012bbai\/Par!\u201d Saeimas frakcijas vad\u012bt\u0101js un parlamenta deput\u0101ts. Vi\u0146a profesion\u0101l\u0101s darb\u012bbas pieredze ietver augst\u0101k\u0101 l\u012bme\u0146a vad\u012bbas poz\u012bcijas valsts, nevalstiskaj\u0101 un biznesa sektor\u0101, k\u0101 ar\u012b vad\u012bbas konsult\u0101ciju un biznesa apm\u0101c\u012bbu pakalpojumus. D. Pav\u013cuts ir konsult\u0113jis vair\u0101kas \u0101rvalstu vald\u012bbas par ekonomikas att\u012bst\u012bbu un politiku p\u0101rejas period\u0101, bijis Latvijas ekonomikas ministrs (2011. \u2013 2014.), Kult\u016bras ministrijas valsts sekret\u0101rs, Swedbank Latvia korporat\u012bvo attiec\u012bbu vad\u012bt\u0101js, Latvijas Tirdzniec\u012bbas un r\u016bpniec\u012bbas kameras valdes loceklis, k\u0101 ar\u012b  ie\u0146\u0113mis citus vado\u0161us amatus. Sav\u0101 konsult\u0101ciju un apm\u0101c\u012bbu praks\u0113 D. Pav\u013cuts piev\u0113r\u0161as l\u012bder\u012bbas un p\u0101rmai\u0146u vad\u012bbas t\u0113m\u0101m, organiz\u0101ciju att\u012bst\u012bbai un inov\u0101cij\u0101m, p\u0101rrunu vad\u012bbai un str\u012bdu risin\u0101\u0161anai, k\u0101 ar\u012b komandas sadarb\u012bbai. Vi\u0146am ir H\u0101rvardas universit\u0101tes ma\u0123istra gr\u0101ds valsts p\u0101rvald\u0113."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/02\/Tanel-Kiik_foto.jpg","name":"Tanels K\u012bks (Tanel Kiik)","position":"Igaunijas republikas vesel\u012bbas un darba ministrs","description":"Tanels K\u012bks ir Igaunijas Centra partijas biedrs. Bijis soci\u0101lo lietu ministrs (2019.-2021.) gadam, premjerministra biroja vad\u012bt\u0101js (2016.-2019.), Igaunijas parlamenta viceprezidenta padomnieks (2012 \u2013 2016). Kop\u0161 2007. gada Tanels K\u012bks ir Igaunijas Abstinences Asoci\u0101cijas biedrs. 2016. gad\u0101 ar izcil\u012bbu absolv\u0113jis Tartu universit\u0101tes P\u0113rnavas koled\u017eu, ieg\u016bstot izgl\u012bt\u012bbu uz\u0146\u0113m\u0113jdarb\u012bb\u0101 un projektu vad\u012bb\u0101."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Marius_Geanta_foto.jpg","name":"Mariuss Geanta (Marius Geant\u0103)","position":"Rum\u0101nijas Medic\u012bnas inov\u0101ciju centra prezidents un l\u012bdzdibin\u0101t\u0101js","description":"Dr. Mariuss Geanta ir Medic\u012bnas inov\u0101ciju centra prezidents un l\u012bdzdibin\u0101t\u0101js \u2013 \u0161\u012b ir organiz\u0101cija, kas b\u0101z\u0113ta Bukarest\u0113, Rum\u0101nij\u0101 un kuras darb\u012bba ir velt\u012bta inov\u0101cij\u0101m vesel\u012bbas apr\u016bpes sektor\u0101. Dr. Mariuss Geanta ir ar\u012b FH Europe Zin\u0101tnisk\u0101s un sabiedr\u012bbas vesel\u012bbas konsultat\u012bv\u0101s komitejas pilnvarot\u0101 persona un l\u012bdzpriek\u0161s\u0113d\u0113t\u0101js, Personaliz\u0113t\u0101s medic\u012bnas starptautisk\u0101 konsorcija (ICPerMed) Izgl\u012bt\u012bbas un m\u0101c\u012bbu programmu darba grupas vad\u012bt\u0101js, Nevienl\u012bdz\u012bbas t\u012bkla (Eiropas v\u0113\u017ea organiz\u0101cijas) vad\u012bbas grupas loceklis un Bukarestes universit\u0101tes asoci\u0113tais profesors (vi\u0146a akad\u0113misk\u0101 darb\u012bbas joma \u2013 sabiedrisk\u0101s attiec\u012bbas un vesel\u012bbas apr\u016bpes sist\u0113ma). Dr. Mariuss Geanta ir personaliz\u0113t\u0101s medic\u012bnas celmlauzis Rum\u0101nij\u0101 un Austrumu un Centr\u0101laj\u0101 Eirop\u0101, kur\u0161 darbojies vair\u0101kos inovat\u012bvos Eiropas m\u0113roga projektos, piem\u0113ram., Inform\u0101cijas tehnolo\u0123ijas: V\u0113\u017ea \u0101rstniec\u012bbas n\u0101kotne; DigiTwins Konsorcijs, Personaliz\u0113t\u0101s medic\u012bnas starptautiskais konsorcijs, Sabiedr\u012bbas vesel\u012bbas genoma t\u012bkls, PECAN, Personaliz\u0113t\u0101s medic\u012bnas izveides \u2018bloki\u2019. Dr. Mariuss Geanta ir vair\u0101k k\u0101 15 gadus ilga pieredze un zin\u0101\u0161anas vesel\u012bbas un zin\u0101tnes komunik\u0101cijas jom\u0101, jo vi\u0146\u0161 ir bijis daudzu medic\u012bnisko \u017eurn\u0101lu galvenais redaktors un izdev\u0113js un vesel\u012bbas komunik\u0101cijas platformu izveidot\u0101js."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Alinta_Hegmane-1.png","name":"Alinta Hegmane","position":"Onkolo\u0123e - \u0137\u012bmijterapeite, Latvija","description":"Alinta Hegmane ir Sertific\u0113ta onkolo\u0123e \u0137\u012bmijterapeite R\u012bgas Austrumu kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas kl\u012bnik\u0101 \u201cLatvijas Onkolo\u0123ijas centrs\u201d, Latvijas Universit\u0101tes asoci\u0113t\u0101 profesore. Alinta Hegmane 1998. gad\u0101 beigusi Latvijas Medic\u012bnas akad\u0113miju, no 1998. l\u012bdz 2002. gadam biju onkolo\u0123ijas rezidente Latvijas Universit\u0101tes Medic\u012bnisk\u0101s P\u0113cdiploma izgl\u012bt\u012bbas instit\u016bt\u0101, bet 2008. gad\u0101 ieguva medic\u012bnas zin\u0101t\u0146u doktora gr\u0101du. Vi\u0146a veic studentu apm\u0101c\u012bbu Latvijas Universit\u0101t\u0113, rezidentu apm\u0101c\u012bbu Latvijas Universit\u0101t\u0113 un R\u012bgas Stradi\u0146a universit\u0101t\u0113. Vado\u0161\u0101 p\u0113tniece kl\u012bniskajos p\u0113t\u012bjumos par kr\u016bts v\u0113zi, nes\u012bk\u0161\u016bnu plau\u0161u v\u0113zi, kolorekt\u0101lo v\u0113zi un nezin\u0101mas prim\u0101ras lokaliz\u0101cijas v\u0113zi. Starptautiski cit\u0113jamu publik\u0101ciju autore."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2021\/12\/Fausta_Simonelyte.jpeg","name":"Fausta \u0160imonel\u012bte (Fausta \u0160imon\u0117lyt\u0117)","position":"Lietuvas V\u0113\u017ea pacientu koal\u012bcijas (POLA) juriskonsulte","description":"Lietuvas V\u0113\u017ea pacientu koal\u012bcijas (POLA juriste un juriskonsulte. Vair\u0101k nek\u0101 3 gadus str\u0101d\u0101jot \u0161aj\u0101 organiz\u0101cij\u0101, Fausta \u0160imonel\u012bte sniedz juridisku atbalstu v\u0113\u017ea pacientu ties\u012bbu un intere\u0161u p\u0101rst\u0101v\u012bbai un aizst\u0101v\u012bbai valsts iest\u0101d\u0113s un da\u017e\u0101dos l\u0113mumu pie\u0146em\u0161anas procesos. Vi\u0146a ir ar\u012b iesaist\u012bta da\u017e\u0101d\u0101s POLA aktivit\u0101t\u0113s . \u012bpa\u0161i taj\u0101s, kas fokus\u0113tas uz nevienl\u012bdz\u012bbas mazin\u0101\u0161anu v\u0113\u017ea apr\u016bpes jom\u0101, pacientu ties\u012bbu un vesel\u012bbas apr\u016bpes pakalpojumu, k\u0101 ar\u012b skr\u012bninga programmu pieejam\u012bbas nodro\u0161in\u0101\u0161anu, pret v\u0113\u017ea pacientiem un v\u0113zi p\u0101rcietu\u0161ajiem v\u0113rst\u0101s diskrimin\u0101cijas nov\u0113r\u0161anu."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2021\/12\/Kozirovskis-2017_final.jpg","name":"Viktors Kozirovskis","position":"Latvijas Universit\u0101tes Medic\u012bnas fakult\u0101tes lektors, Paula Stradi\u0146a Kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas Onkolo\u0123ijas kl\u012bnikas vec\u0101kais onkologs - k\u012bmijterapeits, Latvija","description":"\u0100rsta gr\u0101du ieguvis 2000. gad\u0101 R\u012bgas Stradi\u0146a universit\u0101t\u0113. Latvijas Universit\u0101t\u0113 apguvis interno medic\u012bnu un onkolo\u0123iju. Kop\u0161 2005. gada str\u0101d\u0101 Paula Stradi\u0146a Kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas Onkolo\u0123ijas kl\u012bnik\u0101. Laika posm\u0101 no 2003. l\u012bdz 2009. gadam str\u0101d\u0101ja ar\u012b par de\u017e\u016br\u0101rstu R\u012bgas 1. slimn\u012bc\u0101. Vi\u0146a p\u0113tniecisk\u0101 interese ir s\u012bk\u0161\u016bnu plau\u0161u v\u0113\u017ea rezistences meh\u0101nismi. Viktors Kozirovskis ir ESMO biedrs kop\u0161 2005. gada, bet kop\u0161 no 2020. gada \u2013 ESMO nacion\u0101lais p\u0101rst\u0101vis. Kop\u0161 2015. gada vi\u0146\u0161 ir Latvijas Onkologu asoci\u0101cijas valdes loceklis un sekret\u0101rs, k\u0101 ar\u012b Latvijas onkolo\u0123ijas sertifik\u0101cijas padomes loceklis un sekret\u0101rs."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Dita_Dzerviniece_Small_Final.jpg","name":"Dita Dz\u0113rviniece","position":"PricewaterhouseCoopers Legal Latvia vec\u0101k\u0101 juriste","description":"D. Dz\u0113rviniecei ir vair\u0101k nek\u0101 10 gadu juridisk\u0101 pieredze un pieredze vesel\u012bbas apr\u016bpes un farm\u0101cijas nozaru anal\u012bz\u0113. Vi\u0146a ir vad\u012bjusi  vair\u0101kus p\u0113t\u012bjumus par vesel\u012bbas apr\u016bpes pakalpojumu tirgiem, analiz\u0113jusi z\u0101\u013cu izplat\u012b\u0161anu, cenu noteik\u0161anas meh\u0101nismus, nov\u0113rt\u0113jusi z\u0101\u013cu un medic\u012bnisko pakalpojumu pieejam\u012bbu utt. nacion\u0101l\u0101 un starptautisk\u0101 l\u012bmen\u012b. Pirms pievieno\u0161an\u0101s PwC bija Latvijas Konkurences padomes Juridisk\u0101 departamenta direktora vietniece padomniece konkurences politikas jaut\u0101jumos. Vi\u0146a ir Farm\u0101cijas jomas konsultat\u012bv\u0101s padomes locekle (k\u0101 eksperte), k\u0101 ar\u012b \u0100rvalstu investoru padomes Latvij\u0101 (FICIL) Vesel\u012bbas apr\u016bpes nozares jaut\u0101jumu darba grupas un \u0161\u012bs padomes Konkurences un publisko iepirkumu darba grupas l\u012bdzpriek\u0161s\u0113d\u0113t\u0101ja. Vi\u0146a ir sniegusi konsult\u0101cijas valsts\/pa\u0161vald\u012bbu iest\u0101d\u0113m, biznesa un nevalstiskaj\u0101m organiz\u0101cij\u0101m."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Toivo_Tanavsuu1_F-1.jpg","name":"Toivo Tanavs\u016b (Toivo T\u00e4navs\u016b)","position":"Igaunijas v\u0113\u017ea \u0101rst\u0113\u0161anas labdar\u012bbas fonda V\u00e4hiravifond Kingitud Elu izveidot\u0101js","description":"V\u00e4hiravifond Kingitud Elu tika izveidots 2014. gad\u0101 un kop\u0161 t\u0101 laik\u0101 ir sav\u0101cis priv\u0101tus ziedojumus vair\u0101k nek\u0101 15 miljonu kopv\u0113rt\u012bb\u0101 un t\u0101d\u0113j\u0101di pal\u012bdzot vair\u0101k nek\u0101 1500 Igaunijas v\u0113\u017ea pacientiem ieg\u0101d\u0101ties tos medikamentus, kuru kompens\u0101ciju neparedz nacion\u0101lais vesel\u012bbas pl\u0101ns. Toivo Tanavs\u016b ir iev\u0113rojama pieredze, kas g\u016bta ilgsto\u0161i darbojoties izdevum\u0101 \u201cEesti Ekspress\u201d k\u0101 p\u0113tnieciskajam \u017eurn\u0101listam, ta\u010du \u0161obr\u012bd vi\u0146\u0161 stud\u0113 medic\u012bnu Tartu universit\u0101t\u0113."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Zinta_Uskale_F-1.jpg","name":"Zinta Uskale","position":"NVO \u201cRoz\u0101 vilciena labdar\u012bbas fonds\u201d dibin\u0101t\u0101ja un valdes locekle","description":"Zinta Uskale ir dzimusi Lielbrit\u0101nij\u0101 un desmit gadus nodz\u012bvojusi Francij\u0101, bet pirms vair\u0101k nek\u0101 20 gadiem atgriezusies pie sav\u0101m sen\u010du sakn\u0113m Latvij\u0101. P\u0113c atvese\u013co\u0161an\u0101s no kr\u016bts v\u0113\u017ea diagnozes 2014. gad\u0101, lai sniegtu atbalstu cit\u0101m sieviet\u0113m Latvij\u0101, kuras cie\u0161 no \u0161\u012bs slim\u012bbas, vi\u0146a izveidoja \u201cRoz\u0101 vilciena labdar\u012bbas fondu\u201d. 2019. gad\u0101 fonds s\u0101ka risin\u0101t ar\u012b kr\u016bts vesel\u012bbas jaut\u0101jumus kopum\u0101, organiz\u0113jot regul\u0101ras kampa\u0146as un mudinot visas sievietes r\u016bp\u0113ties par savu vesel\u012bbu, veicot regul\u0101ras k\u0101rt\u0113j\u0101s p\u0101rbaudes. Viena no fonda jaun\u0101kaj\u0101m kampa\u0146\u0101m BalticBest 2020 Award konkurs\u0101 sa\u0146\u0113ma Zelta balvu. 2019. gad\u0101 vi\u0146ai tika diagnostic\u0113ts un \u0101rst\u0113ts ar\u012b reta veida mutes v\u0113zis, t\u0101p\u0113c vi\u0146ai ir diezgan liela v\u0113\u017ea pacientes pieredze \u0161eit, Latvij\u0101. Zinta Uskale\u201d Latvijas onkolo\u0123ijas pacientu organiz\u0101ciju apvien\u012bbas \u201cOnkoalianse\u201d valdes locekle."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/Uldis_Mitenbergs.jpg","name":"Uldis Mitenbergs","position":"Pasaules Vesel\u012bbas organiz\u0101cijas p\u0101rst\u0101vniec\u012bbas Latvij\u0101 vad\u012bt\u0101js","description":"Uldim ir daudzveid\u012bga pieredze, kas ietver praksi \u0101rsta profesij\u0101 , priv\u0101t\u0101 vesel\u012bbas sektora organiz\u0101ciju vad\u012bbu, vesel\u012bbas ekonomikas lektora pien\u0101kumus R\u012bgas Stradi\u0146a universit\u0101t\u0113, vald\u012bbas konsult\u0101cijas vesel\u012bbas apr\u016bpes finans\u0113\u0161anas jaut\u0101jumos un starptautisku organiz\u0101ciju projektu vad\u012bbu, esot gan konsultanta, gan darbinieka status\u0101. Uldis Mitenbergs \u0161obr\u012bd vada PVO p\u0101rst\u0101vniec\u012bbas biroju Latvij\u0101. Uldis vair\u0101k nek\u0101 piecpadsmit gadus ir vad\u012bjis starptautisku uz\u0146\u0113mumu meitas uz\u0146\u0113mumus Baltijas re\u0123ion\u0101. 2011. gad\u0101 vi\u0146\u0161 bija Latvijas vesel\u012bbas ministra padomnieks. Pirms pievieno\u0161an\u0101s Glob\u0101lajam fondam 2015. gad\u0101, vi\u0146\u0161 darboj\u0101s gan k\u0101 pasniedz\u0113js R\u012bgas Stradi\u0146a universit\u0101t\u0113, gan ar\u012b k\u0101 vald\u012bbas un starptautisko organiz\u0101ciju konsultants vesel\u012bbas politikas un finans\u0113\u0161anas jom\u0101. Vi\u0146a konsult\u0101ciju projektu partneru vid\u016b ir Eiropas Vesel\u012bbas sist\u0113mu un politikas nov\u0113ro\u0161anas centrs, Londonas Ekonomikas augstskola un Pasaules Banka. Str\u0101d\u0101jot Glob\u0101laj\u0101 fond\u0101, Uldis p\u0101rvald\u012bja vair\u0101ku miljonu v\u0113rtus invest\u012bciju portfe\u013cus Centr\u0101l\u0101zijas valst\u012bs un vad\u012bja re\u0123ion\u0101lo daudzvalstu tuberkulozes (TB) grantu. Vi\u0146am ir J\u0113las Universit\u0101tes MBA gr\u0101ds un Latvijas Medic\u012bnas akad\u0113mij\u0101 ieg\u016bta \u0101rsta izgl\u012bt\u012bba."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/02\/Inga_Cechanoviciene_final.jpg","name":"Inga \u010cehanovi\u010diene (Inga Cechanoviciene)","position":"Lietuvas vesel\u012bbas ministrijas specializ\u0113t\u0101s vesel\u012bbas apr\u016bpes departamenta vad\u012bt\u0101ja","description":"Ingas \u010cehanovi\u010dienes ieguld\u012bjums valsts politikas att\u012bst\u012bb\u0101 ir specializ\u0113to vesel\u012bbas apr\u016bpes pakalpojumu snieg\u0161anas t\u012bkla organiz\u0113\u0161ana. Vi\u0146as ietekm\u012bg\u0101kie projekti ir strat\u0113\u0123iju izstr\u0101de onkolo\u0123ijas, kardiolo\u0123ijas, traumatolo\u0123ijas, jaundzimu\u0161o vesel\u012bbas apr\u016bpes, telemedic\u012bnas, skr\u012bninga programmu u.c. jom\u0101s. Vi\u0146a akt\u012bvi iesaist\u0101s v\u0113\u017ea profilakses pas\u0101kumos Lietuv\u0101 \u2013 ir Nacion\u0101l\u0101s v\u0113\u017ea kontroles programmas uzraudz\u012bbas komitejas priek\u0161s\u0113d\u0113t\u0101ja vietniece, nacion\u0101lo skr\u012bninga programmu padomes (dzemdes kakla, resn\u0101s zarnas, kr\u016bts, prostatas) locekle, Centr\u0101leiropas onkolo\u0123ijas sadarb\u012bbas grupas locekle. Ingas \u010cehanovi\u010dienes galvenais \u0161\u0101 br\u012b\u017ea izaicin\u0101jums \u2013 uz pacientu v\u0113rstu pakalpojumu stiprin\u0101\u0161ana, tos piel\u0101gojot ko konkr\u0113tam indiv\u012bdam un vi\u0146a vajadz\u012bb\u0101m, \u013caujot vesel\u012bbas speci\u0101listam izmantot savas zin\u0101\u0161anas, pieredzi un prasmes, str\u0101d\u0101jot vesel\u012bbas apr\u016bpes iest\u0101\u017eu t\u012bkl\u0101, kas atbilst \u0161odienas un n\u0101kotnes vajadz\u012bb\u0101m. Vi\u0146as uzman\u012bbas un darba centr\u0101 ir centieni, kas nodro\u0161ina funkciju nedubl\u0113\u0161anos, vesel\u012bbas un soci\u0101lo pakalpojumu integr\u0101ciju, vienl\u012bdz\u012bgu pakalpojumu pieejam\u012bbu vis\u0101 Lietuvas teritorij\u0101, za\u013co koridoru veicin\u0101\u0161anu v\u0113\u017ea slimniekiem un kompens\u0113jamo vesel\u012bbas apr\u016bpes pakalpojumu pieejam\u012bbas palielin\u0101\u0161ana."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/02\/Piotr_Rutkowski_F-e1646120986631.jpg","name":"Pjotrs Rutkovskis (Piotr Rutkowski)","position":"Marijas Sklodovskas-Kir\u012b Nacion\u0101l\u0101 onkolo\u0123ijas p\u0113tniec\u012bbas instit\u016bta Nacion\u0101l\u0101s onkolo\u0123isk\u0101s strat\u0113\u0123ijas un kl\u012bnisko p\u0113t\u012bjumu instit\u016bta direktora vietnieks.","description":"Dr Rutkovskis \u0161obr\u012bd ir Marijas Sklodovskas-Kir\u012b Nacion\u0101l\u0101 onkolo\u0123ijas p\u0113tniec\u012bbas instit\u016bta M\u012bksto audu\/kaulu sarkomas un melanomas noda\u013cas vad\u012bt\u0101js, Nacion\u0101l\u0101s onkolo\u0123isk\u0101s strat\u0113\u0123ijas un kl\u012bnisko p\u0113t\u012bjumu instit\u016bta direktora vietnieks.\r\n\r\nVi\u0146\u0161 ir piedal\u012bjies vair\u0101kos p\u0113tnieku rosin\u0101tos melanomas un sarkomas p\u0113t\u012bjumos. Vi\u0146\u0161 ir ar\u012b Polijas kl\u012bnisk\u0101 GIST re\u0123istra koordinators un vair\u0101ku starptautisku zin\u0101tnisku \u017eurn\u0101lu recenzents, k\u0101 ar\u012b \u017eurn\u0101lu Annals of Surgical Oncology un European Journal of Surgical Oncology redkol\u0113\u0123ijas loceklis.\r\n\r\nDr Rutkovskis ir akt\u012bvs Eiropas V\u0113\u017ea p\u0113tniec\u012bbas un \u0101rstniec\u012bbas organiz\u0101cijas (EORTC) Melanomas grupas M\u012bksto audu un kaulu sarkomas grupas dal\u012bbnieks, kur\u0101 vi\u0146\u0161 vad\u012bja EORTC valdes Viet\u0113j\u0101s \u0101rst\u0113\u0161anas apak\u0161komiteju un Dal\u012bbas komiteju. Vi\u0146\u0161 ir vair\u0101ku Polijas un starptautisko zin\u0101tnisko biedr\u012bbu biedrs (Polijas Onkolo\u0123ijas biedr\u012bbas iev\u0113l\u0113tais prezidents, Polijas \u0136irur\u0123isk\u0101s onkolo\u0123ijas biedr\u012bbas valdes loceklis un sekret\u0101rs, Saistaudu onkolo\u0123ijas biedr\u012bbas biju\u0161ais direktoru padomes loceklis, ASCO Starptautisko lietu komitejas, ESMO Glob\u0101l\u0101s m\u0101c\u012bbu programmas komitejas loceklis.\r\n\r\n\r\nDr. Rutkovskis ir vair\u0101k nek\u0101 500 zin\u0101tnisku rakstu autors vai l\u012bdzautors, tie public\u0113ti Polijas un starptautiskajos \u017eurn\u0101los (ar ietekmes koeficientu virs 4000, indekss-H: 65, cit\u0113\u0161anas indekss >30 000, 2021. gad\u0101 sa\u0146\u0113mis Augsti cit\u0113ta p\u0113tnieka kl\u012bniskaj\u0101 medic\u012bn\u0101 balvu), ir starptautisko sarkomas un melanomas rekomend\u0101ciju autors un l\u012bdzautors. Vi\u0146\u0161 \u013coti cie\u0161i sadarbojas ar savas valsts GIST\/sarkomas un melanomas pacientu aizst\u0101v\u012bbas grup\u0101m, koordin\u0113 Polijas kl\u012bnisko GIST re\u0123istru un ir Polijas Melanomas akad\u0113mijas priek\u0161s\u0113d\u0113t\u0101js. Medic\u012bnas p\u0113t\u012bjumu a\u0123ent\u016bras padomes loceklis. Polijas Vesel\u012bbas ministrijas Nacion\u0101l\u0101s onkolo\u0123isk\u0101s strat\u0113\u0123ijas darba grupas priek\u0161s\u0113d\u0113t\u0101js."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/03\/Kathy-Oliver-IBTA_FINAL.jpg","name":"Keitija Olivera (Kathy Oliver)","position":"Starptautisk\u0101s smadze\u0146u audz\u0113ju alianses priek\u0161s\u0113d\u0113t\u0101ja, Eiropas V\u0113\u017ea organiz\u0101cijas Pacientu konsultat\u012bv\u0101s komitejas l\u012bdzpriek\u0161s\u0113d\u0113t\u0101ja","description":"Ketija Olivera ir Starptautisk\u0101s smadze\u0146u audz\u0113ju alianses (IBTA) priek\u0161s\u0113d\u0113t\u0101ja un l\u012bdzdirektore \u2013 dibin\u0101t\u0101ja. \u0160is ir glob\u0101ls t\u012bkls, kas izveidots 2005. gad\u0101 k\u0101 dinamiska pasaules kopiena smadze\u0146u audz\u0113ju pacientu organiz\u0101cij\u0101m un citiem, kas iesaist\u012bti neiroonkolo\u0123ijas jom\u0101.\r\n\r\nKetija ir iesaist\u012bta v\u0113\u017ea pacientu ties\u012bbu aizst\u0101v\u012bb\u0101 un ir l\u012bdzautore gr\u0101mat\u0101m \u201cEiropas v\u0113\u017ea pacienta ties\u012bbu akts\u201d (2014), \u201cEiropas v\u0113\u017ea prakses kodekss\u201d (2020) un \u201cSmadze\u0146u audz\u0113ju pacientu ties\u012bbu harta\u201d (2020). Vi\u0146a bie\u017ei uzst\u0101jas starptautisk\u0101s v\u0113\u017ea un neiroonkolo\u0123ijas konferenc\u0113s un piedal\u0101s augsta l\u012bme\u0146a, daudzu ieinteres\u0113to pu\u0161u \u012bstenotos projektos un komitej\u0101s, kas koncentr\u0113jas uz pacientu zi\u0146otajiem rezult\u0101tiem, dz\u012bves kvalit\u0101ti, \u0101rst\u0113\u0161anas vadl\u012bnij\u0101m, retajiem v\u0113\u017eiem, normat\u012bvajiem jaut\u0101jumiem un atbalsto\u0161o un paliat\u012bvo apr\u016bpi.\r\nVi\u0146a ir autore\/l\u012bdzautore pla\u0161am zin\u0101tnisku \u017eurn\u0101lu rakstu, gr\u0101matu noda\u013cu un citos izdevumos public\u0113tu rakstu kl\u0101stam par smadze\u0146u audz\u0113jiem, pacientu ties\u012bbu aizst\u0101v\u012bbu, normat\u012bvajiem jaut\u0101jumiem, COVID-19, atbalsto\u0161o apr\u016bpi un cit\u0101m ar onkolo\u0123iju saist\u012bt\u0101m t\u0113m\u0101m. Vi\u0146a ir EUPATI (Eiropas Pacientu akad\u0113mijas) stipendi\u0101te, Eiropas Onkolo\u0123ijas skolas koled\u017eas (ESCO) m\u0101c\u012bbsp\u0113ks; Eiropas V\u0113\u017ea organiz\u0101cijas Pacientu konsultat\u012bv\u0101s komitejas l\u012bdzpriek\u0161s\u0113d\u0113t\u0101ja un Eiropas Reto v\u0113\u017eu organiz\u0101cijas, k\u0101 ar\u012b un EURACAN, Pieaugu\u0161o v\u0113\u017ea (sol\u012bdu audz\u0113ju) Eiropas references t\u012bkla koordin\u0101cijas komiteju locekle. Ketijas d\u0113lam Kolinam 2004. gad\u0101 24 gadu vecum\u0101 tika diagnostic\u0113ts smadze\u0146u audz\u0113js, un vi\u0146\u0161 nomira 2011.  gada august\u0101 32 gadu vecum\u0101.\r\n\r\nKetija min sava d\u0113la \"neticamo drosmi, ap\u0146\u0113m\u012bbu un stingr\u012bbu\" k\u0101 dzin\u0113jsp\u0113ku un iedvesmu savai iesaistei starptautiskaj\u0101 smadze\u0146u audz\u0113ju un reto v\u0113\u017ea kopien\u0101s."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/03\/Kristiina_Ojamaa-1.jpg","name":"Krist\u012bna Ojam\u0101 (Kristiina Ojamaa)","position":"Tartu Universit\u0101tes slimn\u012bcas Hematolo\u0123ijas un onkolo\u0123ijas kl\u012bnikas vad\u012bt\u0101ja","description":"Krist\u012bne Ojam\u0101 kop\u0161 2021. gada maija ir Tartu universit\u0101tes slimn\u012bcas hematolo\u0123ijas-onkolo\u0123ijas kl\u012bnikas vad\u012bt\u0101ja, k\u0101 ar\u012b vec\u0101k\u0101 apm\u0101c\u012btties\u012bg\u0101 \u0101rste onkolo\u0123ij\u0101. Pirms tam vi\u0146a bija Tallinas Austrumu centr\u0101l\u0101s slimn\u012bcas Onkolo\u0123ijas centra vad\u012bt\u0101ja. K. Ojam\u0101 2020. gad\u0101 Tartu universit\u0101t\u0113 ir aizst\u0101v\u0113jusi doktora disert\u0101ciju par t\u0113mu \u201cGinekolo\u0123isk\u0101 v\u0113\u017ea epidemiolo\u0123ija Igaunij\u0101\u201d, k\u0101 ar\u012b darbojas Igaunijas Onkologu biedr\u012bbas vald\u0113. \u0160obr\u012bd vi\u0146as darba galvenie m\u0113r\u0137i ir iesp\u0113jami pietuvin\u0101t un stiprin\u0101t v\u0113\u017ea apr\u016bpi pacientu dz\u012bvesvietai, uzlabot vi\u0146u \u0101rstniec\u012bbas procesa norisi, k\u0101 ar\u012b ieviest prec\u012bzijas medic\u012bnu v\u0113\u017ea ikdienas apr\u016bp\u0113."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/03\/Jacek_Maciejewski_FINAL-1.jpg","name":"Jaceks Macijevskis (Jacek Maciejewski)","position":"Rak'n'Roll Foundation valdes loceklis, Polija","description":"Jacek Maciejewski ir Rak'n'Roll Foundation valdes loceklis, vi\u0146a atbild\u012bba \u2013 fonda un t\u0101 z\u012bmola vad\u012bbu. Jaceks Macijevskis Var\u0161avas Universit\u0101t\u0113 ir ieguvis ma\u0123istra gr\u0101du pedago\u0123ij\u0101, k\u0101 ar\u012b pabeidzis p\u0113cdiploma kursu socioterapij\u0101. K\u0101du laiku str\u0101d\u0101jis kl\u012bnik\u0101, kas sniedz psiholo\u0123isko apr\u016bpi, bet kop\u0161 1996. gada nodarbojas ar rekl\u0101mu k\u0101 soci\u0101l\u0101s komunik\u0101cijas speci\u0101lists. Vi\u0146\u0161 izgudroja Rak'n'Roll fonda nosaukumu [\u2018rak' po\u013cu valod\u0101 noz\u012bm\u0113 \u2018v\u0113zis\u2019] un izveidoja t\u0101 komunik\u0101cijas strat\u0113\u0123iju. Vi\u0146\u0161 ir bijis atbild\u012bgs par liel\u0101ko da\u013cu fonda soci\u0101lo kampa\u0146u, kuru rezult\u0101t\u0101 \u0161\u012b NVO iemantojusi atpaz\u012bstam\u012bbu."}]},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Run\u0101t\u0101ji - Cancer Equality<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cancerequality.eu\/lv\/speakers\/\" \/>\n<meta property=\"og:locale\" content=\"lv_LV\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Run\u0101t\u0101ji - Cancer Equality\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cancerequality.eu\/lv\/speakers\/\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Equality\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-26T08:05:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/onko_fb.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers\\\/\",\"url\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers\\\/\",\"name\":\"Run\u0101t\u0101ji - Cancer Equality\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#website\"},\"datePublished\":\"2021-12-09T11:27:21+00:00\",\"dateModified\":\"2025-05-26T08:05:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers\\\/#breadcrumb\"},\"inLanguage\":\"lv-LV\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[[\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers\\\/\"]]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Speakers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#website\",\"url\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/\",\"name\":\"Cancer Equality\",\"description\":\"On Equality in Beating Cancer\",\"publisher\":{\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lv-LV\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#organization\",\"name\":\"Cancer Equality\",\"url\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lv-LV\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cancerequality.eu\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/onko_fb.jpg\",\"contentUrl\":\"https:\\\/\\\/cancerequality.eu\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/onko_fb.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Cancer Equality\"},\"image\":{\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Run\u0101t\u0101ji - Cancer Equality","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cancerequality.eu\/lv\/speakers\/","og_locale":"lv_LV","og_type":"article","og_title":"Run\u0101t\u0101ji - Cancer Equality","og_url":"https:\/\/cancerequality.eu\/lv\/speakers\/","og_site_name":"Cancer Equality","article_modified_time":"2025-05-26T08:05:45+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/onko_fb.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cancerequality.eu\/lv\/speakers\/","url":"https:\/\/cancerequality.eu\/lv\/speakers\/","name":"Run\u0101t\u0101ji - Cancer Equality","isPartOf":{"@id":"https:\/\/cancerequality.eu\/lv\/#website"},"datePublished":"2021-12-09T11:27:21+00:00","dateModified":"2025-05-26T08:05:45+00:00","breadcrumb":{"@id":"https:\/\/cancerequality.eu\/lv\/speakers\/#breadcrumb"},"inLanguage":"lv-LV","potentialAction":[{"@type":"ReadAction","target":[["https:\/\/cancerequality.eu\/lv\/speakers\/"]]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cancerequality.eu\/lv\/speakers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cancerequality.eu\/lv\/"},{"@type":"ListItem","position":2,"name":"Speakers"}]},{"@type":"WebSite","@id":"https:\/\/cancerequality.eu\/lv\/#website","url":"https:\/\/cancerequality.eu\/lv\/","name":"Cancer Equality","description":"On Equality in Beating Cancer","publisher":{"@id":"https:\/\/cancerequality.eu\/lv\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cancerequality.eu\/lv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lv-LV"},{"@type":"Organization","@id":"https:\/\/cancerequality.eu\/lv\/#organization","name":"Cancer Equality","url":"https:\/\/cancerequality.eu\/lv\/","logo":{"@type":"ImageObject","inLanguage":"lv-LV","@id":"https:\/\/cancerequality.eu\/lv\/#\/schema\/logo\/image\/","url":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/onko_fb.jpg","contentUrl":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/onko_fb.jpg","width":1200,"height":630,"caption":"Cancer Equality"},"image":{"@id":"https:\/\/cancerequality.eu\/lv\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/pages\/116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/comments?post=116"}],"version-history":[{"count":30,"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/pages\/116\/revisions"}],"predecessor-version":[{"id":930,"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/pages\/116\/revisions\/930"}],"wp:attachment":[{"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/media?parent=116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}